Novartis Ag (NVS) Interest Coverage Ratio (QoQ) (2009 - 2023)
Novartis Ag (NVS) Interest Coverage Ratio (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 100.05% |
| Mar 31, 2023 | -48,992.00% |
| Dec 31, 2022 | -1,459.01% |
| Sep 30, 2022 | 70.38% |
| Jun 30, 2022 | 99.99% |
| Mar 31, 2022 | -565,725.03% |
| Dec 31, 2021 | -732.96% |
| Sep 30, 2021 | 79.26% |
| Jun 30, 2021 | 99.98% |
| Mar 31, 2021 | -279,407.19% |
| Dec 31, 2020 | 99.97% |
| Sep 30, 2020 | -831,150.16% |
| Jun 30, 2020 | -5,602.97% |
| Jun 30, 2019 | -822.40% |
| Mar 31, 2019 | 69.97% |
| Dec 31, 2018 | 35.82% |
| Sep 30, 2018 | 38.91% |
| Jun 30, 2018 | -446.73% |
| Mar 31, 2018 | 57.83% |
| Dec 31, 2017 | 47.42% |